Analysis shows genetic and genomic testing improves outcomes in patients with breast cancer, suggesting cost-effective treatment strategies.
Compared to no testing, the full testing strategy of genetic and genomic testing was more effective at a lower cost or was cost-effective, supporting the goal to increase the survival and the quality-of-life of women with breast cancer along the cancer care continuum.
No takes yet. Share an insight, caveat, or question.
Gouldson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: